rs140682

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000810.4(GABRA5):​c.606T>C​(p.Val202Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.587 in 1,613,496 control chromosomes in the GnomAD database, including 281,639 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 31586 hom., cov: 33)
Exomes 𝑓: 0.58 ( 250053 hom. )

Consequence

GABRA5
NM_000810.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.209

Publications

23 publications found
Variant links:
Genes affected
GABRA5 (HGNC:4079): (gamma-aminobutyric acid type A receptor subunit alpha5) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Transcript variants utilizing three different alternative non-coding first exons have been described. [provided by RefSeq, Jul 2008]
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]
GABRB3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 43
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epilepsy, childhood absence, susceptibility to, 5
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 15-26937210-T-C is Benign according to our data. Variant chr15-26937210-T-C is described in ClinVar as Benign. ClinVar VariationId is 1285288.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.209 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.795 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000810.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA5
NM_000810.4
MANE Select
c.606T>Cp.Val202Val
synonymous
Exon 8 of 11NP_000801.1
GABRA5
NM_001165037.2
c.606T>Cp.Val202Val
synonymous
Exon 8 of 11NP_001158509.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA5
ENST00000335625.10
TSL:1 MANE Select
c.606T>Cp.Val202Val
synonymous
Exon 8 of 11ENSP00000335592.5
GABRB3
ENST00000541819.6
TSL:1
c.200+2027A>G
intron
N/AENSP00000442408.2
GABRA5
ENST00000355395.9
TSL:5
c.606T>Cp.Val202Val
synonymous
Exon 7 of 10ENSP00000347557.5

Frequencies

GnomAD3 genomes
AF:
0.634
AC:
96402
AN:
152012
Hom.:
31530
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.802
Gnomad AMI
AF:
0.646
Gnomad AMR
AF:
0.534
Gnomad ASJ
AF:
0.482
Gnomad EAS
AF:
0.675
Gnomad SAS
AF:
0.592
Gnomad FIN
AF:
0.657
Gnomad MID
AF:
0.443
Gnomad NFE
AF:
0.560
Gnomad OTH
AF:
0.596
GnomAD2 exomes
AF:
0.586
AC:
145971
AN:
249264
AF XY:
0.583
show subpopulations
Gnomad AFR exome
AF:
0.811
Gnomad AMR exome
AF:
0.495
Gnomad ASJ exome
AF:
0.486
Gnomad EAS exome
AF:
0.660
Gnomad FIN exome
AF:
0.651
Gnomad NFE exome
AF:
0.567
Gnomad OTH exome
AF:
0.568
GnomAD4 exome
AF:
0.582
AC:
850623
AN:
1461366
Hom.:
250053
Cov.:
49
AF XY:
0.581
AC XY:
422368
AN XY:
726996
show subpopulations
African (AFR)
AF:
0.817
AC:
27343
AN:
33476
American (AMR)
AF:
0.501
AC:
22385
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.487
AC:
12735
AN:
26132
East Asian (EAS)
AF:
0.680
AC:
26979
AN:
39696
South Asian (SAS)
AF:
0.585
AC:
50434
AN:
86238
European-Finnish (FIN)
AF:
0.648
AC:
34628
AN:
53398
Middle Eastern (MID)
AF:
0.475
AC:
2739
AN:
5766
European-Non Finnish (NFE)
AF:
0.574
AC:
638424
AN:
1111582
Other (OTH)
AF:
0.579
AC:
34956
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
18426
36853
55279
73706
92132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17852
35704
53556
71408
89260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.634
AC:
96512
AN:
152130
Hom.:
31586
Cov.:
33
AF XY:
0.634
AC XY:
47177
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.803
AC:
33316
AN:
41514
American (AMR)
AF:
0.534
AC:
8158
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.482
AC:
1674
AN:
3470
East Asian (EAS)
AF:
0.676
AC:
3485
AN:
5158
South Asian (SAS)
AF:
0.593
AC:
2860
AN:
4822
European-Finnish (FIN)
AF:
0.657
AC:
6965
AN:
10600
Middle Eastern (MID)
AF:
0.452
AC:
133
AN:
294
European-Non Finnish (NFE)
AF:
0.560
AC:
38090
AN:
67976
Other (OTH)
AF:
0.592
AC:
1247
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1774
3548
5321
7095
8869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.596
Hom.:
19104
Bravo
AF:
0.636
Asia WGS
AF:
0.632
AC:
2200
AN:
3478
EpiCase
AF:
0.552
EpiControl
AF:
0.560

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Developmental and epileptic encephalopathy, 79 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
1.2
DANN
Benign
0.62
PhyloP100
0.21
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140682; hg19: chr15-27182357; COSMIC: COSV59484940; COSMIC: COSV59484940; API